MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 110.00
-15.00 (-12.00%)
Mar 6, 2026, 11:30 AM JST
MedRx Revenue
In the year 2025, MedRx had annual revenue of 128.00M JPY, down -50.19%. MedRx had revenue of 10.00M in the quarter ending December 31, 2025, with 400.00% growth.
Revenue
128.00M
Revenue Growth
-50.19%
P/S Ratio
57.97
Revenue / Employee
5.82M
Employees
22
Market Cap
7.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 128.00M | -129.00M | -50.19% |
| Dec 31, 2024 | 257.00M | 228.00M | 786.21% |
| Dec 31, 2023 | 29.00M | -30.00M | -50.85% |
| Dec 31, 2022 | 59.00M | 51.00M | 637.50% |
| Dec 31, 2021 | 8.00M | -107.00M | -93.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma Foods International | 66.38B |
| Fuso Pharmaceutical Industries,Ltd. | 62.17B |
| Nippon Chemiphar | 32.52B |
| Morishita Jintan | 12.87B |
| Wakamoto Pharmaceutical | 9.43B |
| Taiko Pharmaceutical | 6.40B |
| WDB coco | 4.98B |
| SymBio Pharmaceuticals | 1.31B |